Table 2.
Entire follow-up period |
|||
---|---|---|---|
PN cases |
Non-PN controls |
p value | |
n = 1387 | n = 2594 | ||
All-cause healthcare utilization (PPPM) | |||
Patients with an inpatient admission, % | 77.4% | 67.2% | <0.001 |
Admissions PPPM, mean (SD) | 0.11 (0.14) | 0.10 (0.15) | 0.019 |
Patients with an admission, mean (SD) | 0.14 (0.14) | 0.15 (0.16) | 0.373 |
Patients with an ER visit, % | 67.8% | 58.4% | <0.001 |
ER visits PPPM, mean (SD) | 0.13 (0.33) | 0.11 (0.22) | 0.015 |
Patients with a visit, mean (SD) | 0.19 (0.39) | 0.19 (0.26) | 0.629 |
Patients with an outpatient office visit, N% | 97.9% | 96.6% | 0.024 |
Outpatient office visits PPPM, mean (SD) | 1.7 (1.2) | 1.6 (1.2) | 0.142 |
Patients with a visit, mean (SD) | 1.7 (1.2) | 1.7 (1.1) | 0.342 |
Patients with outpatient hospital-based visits, % | 98.7% | 96.3% | <0.001 |
Outpatient hospital-based visits PPPM, mean (SD) | 13.3 (14.7) | 11.1 (17.8) | <0.001 |
Patients with a visit, mean (SD) | 13.5 (14.7) | 11.5 (18.0) | <0.001 |
Patients with a laboratory test, % | 90.9% | 87.9% | 0.003 |
Laboratory tests PPPM, mean (SD) | 3.7 (5.0) | 4.1 (5.5) | 0.018 |
Patients with a test, mean (SD) | 4.1 (5.0) | 4.7 (5.6) | 0.001 |
Patients filling an outpatient prescription, % | 97.2% | 97.1% | 0.941 |
Outpatient prescriptions PPPM, mean (SD) | 4.6 (2.6) | 4.0 (2.5) | <0.001 |
Patients with a prescription, mean (SD) | 4.7 (2.5) | 4.2 (2.4) | <0.001 |
ER, emergency department (room); PN, peripheral neuropathy; PPPM, per patient per month; SD, standard deviation.